Intravenous immunoglobulin therapy for resistant ocular Behcet's disease

Aims-The present report was aimed at finding out whether gammaglobulin coul d have a role in treating ocular Behcet's disease (BD) refractory to accept ed medical therapy. Methods-Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results-All six eyes of all four patients showed good response to gammaglob ulin therapy. Conclusion-Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to subs tantiate this impression.